1Collaborative Research Group of National“Eighth Five year”Project(85 915 02 01) (Fu Wai Hospital,CAMS and PUMC,Beijing 100037).急性心肌梗死尿激酶溶栓治疗开始时间对疗效的影响[J].中国循环杂志,1996,11(7):387-389. 被引量：47
4[1]Jonathan S. Scharfstein,Dana R. Abendschein,et al. Usefulness of fib rinogenolytic and procoagulant markers during thrombolytic therapy in pre dicting clinical outcomes in acute myocardial infarction[J]. Am J Cardiol,1996,78:503-510.
5[2]1996 Update. ACC/AHA Guidelines for the management of patients with a cute myocardial infarction: executive summary and recommendations. A report of the American college of cardiology/American heart association task force on practice guidelines(Committee on management of acute myocardial infarction)
6[3]Piera Angelic Merlini PA,Marco Cattaneo M,et al. Activation of hemostatic system during thrombolytic therapy[J]. Am J Cardiol, 1 993,72: 59G- 65G.
7[4]Eisenberg PR,Sherman LA,Jaffe AD. Paradoxic elevation of fibrinopep tide A after streptokinase:evidence for continued thrombosis despite fibrinolysis[J]. J Am Coll Candiol,1987,10: 527-529.
8[5]Owen J,Friedman KD,Grossman BA,et al. Thrombolytic therapy with tis sue type plasminogen activator or streptokinase induced transient thrombin activity[J]. Blood, 1988,72 : 616-620.
9[6]Gulba DC,Barthels M,Westhoff-Bleck M,et al. Increased thrombin levels during thrombolytic therapy in acute myocardial infarction[J]. Circulation,1991,83:937-944.
10[7]Rapold HJ,de Bono D,Amold AERt et al. For the European Cooperative Study Plasma fibrinopeptide A levels in patients with myocardial infarction treated with alteplase[J]. Circulation, 1992, 85 : 928-934.
